Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
| ▸ | QPCT | Q16769 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | QPCTL | Q9NXS2 | 1/20 | 0.41 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.30 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.30 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2840229 | 0.77 | — | — | |
| SCHEMBL2840228 | 0.77 | — | — | |
| SCHEMBL28486037 | 0.77 | — | — | |
| SCHEMBL16542717 | 0.77 | — | — | |
| SCHEMBL5087445 | 0.77 | — | — | |
| SCHEMBL28663405 | 0.77 | CYP2B6 (0.32) | NFKB1QPCTHSD17B10QPCTLCYP3A4 | |
| Hydrochloric Acid SCHEMBL28847875 | 0.75 | — | — | |
| Pyrazine SCHEMBL28047911 | 0.73 | QPCT (0.40) | NFKB1QPCTHSD17B10QPCTLTBXAS1 | |
| SCHEMBL3277667 | 0.71 | — | — | |
| SCHEMBL3314432 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1288309-A1 | Methods for labeling L-nucleic acids | Noxxon Pharma AG (DE) | 2003-03-05 | — | — | EP | disclosed |